Organizing a mucosal defense
Rodney D. Newberry
Department of Internal Medicine, Division of Gastroenterology, Washington University School of Medicine, St. Louis, MO, USA.
Search for more papers by this authorCorresponding Author
Robin G. Lorenz
Department of Pathology, University of Alabama at Birmingham, Birmingham, AL, USA.
* Robin Lorenz Department of Pathology University of Alabama at Birmingham 845 19th Street South BBRB 730 Birmingham, AL 35294-2170 USA Tel.: +1 205 934 0676 Fax: +1 205 975 8310 E-mail: [email protected]Search for more papers by this authorRodney D. Newberry
Department of Internal Medicine, Division of Gastroenterology, Washington University School of Medicine, St. Louis, MO, USA.
Search for more papers by this authorCorresponding Author
Robin G. Lorenz
Department of Pathology, University of Alabama at Birmingham, Birmingham, AL, USA.
* Robin Lorenz Department of Pathology University of Alabama at Birmingham 845 19th Street South BBRB 730 Birmingham, AL 35294-2170 USA Tel.: +1 205 934 0676 Fax: +1 205 975 8310 E-mail: [email protected]Search for more papers by this authorAbstract
Summary: Gastrointestinal associated lymphoid tissue can be divided into loosely organized effector sites, which include the lamina propria and intraepithelial lymphocytes, and more organized structures, such as mesenteric lymph nodes (LNs), Peyer's patches (PPs), isolated lymphoid follicles, and cryptopatches (CPs). These organized structures in the gastrointestinal tract have been hypothesized to play the role of primary lymphoid organ, supporting the extrathymic development of T lymphocytes (CPs), secondary lymphoid organs involved in the induction of the mucosal immune response (PPs), and tertiary lymphoid structures whose function is still under debate (isolated lymphoid follicles). The most widely studied lymphoid structure found in the small intestine is the PP. PPs are secondary lymphoid structures, and their development and function have been extensively investigated. However, single lymphoid aggregates resembling PPs have been also described in humans and in the murine small intestines. These isolated lymphoid follicles have both germinal centers and an overlying follicle-associated epithelium, suggesting that they also can function as inductive sites for the mucosal immune response. This review compares and contrasts the development and function of the four main organized gastrointestinal lymphoid tissues: CPs, isolated lymphoid follicles, PPs, and mesenteric LNs.
References
- 1 Kanamori Y, et al. Identification of novel lymphoid tissues in murine intestinal mucosa where clusters of c-kit+ IL-7R+ Thy1+ lympho-hemopoietic progenitors develop. J Exp Med 1996; 184: 1449–1459.
- 2 Taylor RT, Lugering A, Newell KA, Williams IR. Intestinal cryptopatch formation in mice requires lymphotoxin alpha and the lymphotoxin beta receptor. J Immunol 2004; 173: 7183–7189.
- 3 Medvedev A, Chistokhina A, Hirose T, Jetten AM. Genomic structure and chromosomal mapping of the nuclear orphan receptor ROR gamma (RORC) gene. Genomics 1997; 46: 93–102.
- 4 He YW, Deftos ML, Ojala EW, Bevan MJ. RORgamma t, a novel isoform of an orphan receptor, negatively regulates Fas ligand expression and IL-2 production in T cells. Immunity 1998; 9: 797–806.
- 5
Villey I,
De Chasseval R,
De Villartay JP.
RORgammaT, a thymus-specific isoform of the orphan nuclear receptor RORgamma / TOR, is up-regulated by signaling through the pre-T cell receptor and binds to the TEA promoter.
Eur J Immunol
1999; 29: 4072–4080.
10.1002/(SICI)1521-4141(199912)29:12<4072::AID-IMMU4072>3.0.CO;2-E CAS PubMed Web of Science® Google Scholar
- 6 Eberl G, Littman DR. Thymic origin of intestinal alphabeta T Cells Revealed by Fate Mapping of RORgammat+ Cells. Science 2004; 305: 248–251.
- 7 Eberl G, Marmon S, Sunshine MJ, Rennert PD, Choi Y, Littman DR. An essential function for the nuclear receptor RORgamma (t) in the generation of fetal lymphoid tissue inducer cells. Nat Immunol 2004; 5: 64–73.
- 8 Laky K, et al. Enterocyte expression of interleukin 7 induces development of gammadelta T cells and Peyer's patches. J Exp Med 2000; 191: 1569–1580.
- 9 Dejardin E, et al. The lymphotoxin-beta receptor induces different patterns of gene expression via two NF-kappaB pathways. Immunity 2002; 17: 525–535.
- 10 Muller JR, Siebenlist U. Lymphotoxin beta receptor induces sequential activation of distinct NF-kappa B factors via separate signaling pathways. J Biol Chem 2003; 278: 12006–12012.
- 11 Onai N, Kitabatake M, Zhang YY, Ishikawa H, Ishikawa S, Matsushima K. Pivotal role of CCL25 (TECK) -CCR9 in the formation of gut cryptopatches and consequent appearance of intestinal intraepithelial T lymphocytes. Int Immunol 2002; 14: 687–694.
- 12 Suzuki K, et al. Gut cryptopatches: direct evidence of extrathymic anatomical sites for intestinal T lymphopoiesis. Immunity 2000; 13: 691–702.
- 13 Lefrancois L, Olson S. Reconstitution of the extrathymic intestinal T cell compartment in the absence of irradiation. J Immunol 1997; 159: 538–541.
- 14 Lin T, et al. CD3 – CD8+ intestinal intraepithelial lymphocytes (IEL) and the extrathymic development of IEL. Eur J Immunol 1994; 24: 1080–1087.
- 15 Rocha B, Vassalli P, Guy-Grand D. Thymic and extrathymic origins of gut intraepithelial lymphocyte populations in mice. J Exp Med 1994; 180: 681–686.
- 16 Guy-Grand D, Cerf-Bensussan N, Malissen B, Malassis-Seris M, Briottet C, Vassalli P. Two gut intraepithelial CD8+ lymphocyte populations with different T cell receptors: a role for the gut epithelium in T cell differentiation. J Exp Med 1991; 173: 471–481.
- 17 Oida T, et al. Role of gut cryptopatches in early extrathymic maturation of intestinal intraepithelial T cells. J Immunol 2000; 164: 3616–3626.
- 18 Saito H, et al. Generation of intestinal T cells from progenitors residing in gut cryptopatches. Science 1998; 280: 275–278.
- 19 Kurebayashi S, et al. Retinoid-related orphan receptor gamma (RORgamma) is essential for lymphoid organogenesis and controls apoptosis during thymopoiesis. Proc Natl Acad Sci USA 2000; 97: 10132–10137.
- 20 Sun Z, et al. Requirement for RORgamma in thymocyte survival and lymphoid organ development. Science 2000; 288: 2369–2373.
- 21 Pabst O, et al. Cryptopatches and isolated lymphoid follicles: dynamic lymphoid tissues dispensable for the generation of intraepithelial lymphocytes. Eur J Immunol 2005; 35: 98–107.
- 22 Newberry RD, McDonough JS, McDonald KG, Lorenz RG. Postgestational lymphotoxin/lymphotoxin Beta receptor interactions are essential for the presence of intestinal B lymphocytes. J Immunol 2002; 168: 4988–4997.
- 23 Cupedo T, Kraal G, Mebius RE. The role of CD45+CD4+CD3 – cells in lymphoid organ development. Immunol Rev 2002; 189: 41–50.
- 24 Mebius RE, Rennert P, Weissman IL. Developing lymph nodes collect CD4+CD3 – LTbeta+ cells that can differentiate to APC, NK cells, and follicular cells but not T or B cells. Immunity 1997; 7: 493–504.
- 25 Rennert PD, Browning JL, Mebius R, Mackay F, Hochman PS. Surface lymphotoxin alpha/beta complex is required for the development of peripheral lymphoid organs. J Exp Med 1996; 184: 1999–2006.
- 26 Mariathasan S, Matsumoto M, Baranyay F, Nahm MH, Kanagawa O, Chaplin DD. Absence of lymph nodes in lymphotoxin-alpha (LT alpha) -deficient mice is due to abnormal organ development, not defective lymphocyte migration. J Inflamm 2002; 45: 72–78.
- 27 Fujimura Y, Kamoi R, Iida M. Pathogenesis of aphthoid ulcers in Crohn's disease: correlative findings by magnifying colonoscopy, electron microscopy, and immunohistochemistry. Gut 1996; 38: 724–732.
- 28 Kaiserling E. Newly-formed lymph nodes in the submucosa in chronic inflammatory bowel disease. Lymphology 2001; 34: 22–29.
- 29 Lockhart-Mummery HE, Morson BC. Crohn's disease (regional enteritis) of the large intestine and its distinction from ulcerative colitis. Gut 1960; 1: 87–105.
- 30 Hamada H, et al. Identification of multiple isolated lymphoid follicles on the antimesenteric wall of the mouse small intestine. J Immunol 2002; 168: 57–64.
- 31 Lorenz RG, Chaplin DD, McDonald KG, McDonough JS, Newberry RD. Isolated lymphoid follicle formation is inducible and dependent upon lymphotoxin-sufficient b lymphocytes, lymphotoxin beta receptor, and TNF receptor I function. J Immunol 2003; 170: 5475–5482.
- 32 Lorenz RG, Newberry RD. Isolated lymphoid follicles can function as sites for induction of mucosal immune responses. Ann N Y Acad Sci 2004; 1029: 44–57.
- 33 Suzuki K, et al. Aberrant expansion of segmented filamentous bacteria in IgA-deficient gut. Proc Natl Acad Sci USA 2004; 101: 1981–1986.
- 34 Fagarasan S, Muramatsu M, Suzuki K, Nagaoka H, Hiai H, Honjo T. Critical roles of activation-induced cytidine deaminase in the homeostasis of gut flora. Science 2002; 298: 1424–1427.
- 35 Guo W, Mourad W, Charron D, Al-Daccak R. Ligation of MHC class II molecules differentially upregulates TNF beta gene expression in B cell lines of different MHC class II haplotypes. Hum Immunol 1999; 60: 312–322.
- 36 Worm M, Geha RS. CD40 ligation induces lymphotoxin alpha gene expression in human B cells. Int Immunol 1994; 6: 1883–1890.
- 37 Worm M, Geha RS. CD40-mediated lymphotoxin alpha expression in human B cells is tyrosine kinase dependent. Eur J Immunol 1995; 25: 2438–2444.
- 38 Worm M, Geha RS. Activation of tumor necrosis factor-alpha and lymphotoxin-alpha via anti-CD40 in human B cells. Int Arch Allergy Immunol 1995; 107: 368–369.
- 39
Worm MM,
Tsytsykova A,
Geha RS.
CD40 ligation and IL-4 use different mechanisms of transcriptional activation of the human lymphotoxin alpha promoter in B cells.
Eur J Immunol
1998; 28: 901–906.
10.1002/(SICI)1521-4141(199803)28:03<901::AID-IMMU901>3.0.CO;2-S CAS PubMed Web of Science® Google Scholar
- 40 Ansel KM, et al. A chemokine-driven positive feedback loop organizes lymphoid follicles. Nature 2000; 406: 309–314.
- 41 Shikina T, et al. IgA class switch occurs in the organized nasopharynx- and gut-associated lymphoid tissue, but not in the diffuse lamina propria of airways and gut. J Immunol 2004; 172: 6259–6264.
- 42 Muramatsu M, Kinoshita K, Fagarasan S, Yamada S, Shinkai Y, Honjo T. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 2000; 102: 553–563.
- 43 Hjelmstrom P. Lymphoid neogenesis: de novo formation of lymphoid tissue in chronic inflammation through expression of homing chemokines. J Leukoc Biol 2001; 69: 331–339.
- 44 Grant AJ, et al. Hepatic expression of secondary lymphoid chemokine (CCL21) promotes the development of portal-associated lymphoid tissue in chronic inflammatory liver disease. Am J Pathol 2002; 160: 1445–1455.
- 45 Yeung MM, et al. Characterisation of mucosal lymphoid aggregates in ulcerative colitis: immune cell phenotype and TcR-gammadelta expression. Gut 2000; 47: 215–227.
- 46 Eidt S, Stolte M. Prevalence of lymphoid follicles and aggregates in Helicobacter pylori gastritis in antral and body mucosa. J Clin Pathol 1993; 46: 832–835.
- 47 Makala LH, Suzuki N, Nagasawa H. Peyer's patches: organized lymphoid structures for the induction of mucosal immune responses in the intestine. Pathobiology 2002; 70: 55–68.
- 48 Cornes JS. Peyer's patches in the human gut. Proc R Soc Med 1965; 58: 716.
- 49 Kraehenbuhl JP, Neutra MR. Epithelial M cells: differentiation and function. Annu Rev Cell Dev Biol 2000; 16: 301–332.
- 50 Owen RL, Jones AL. Epithelial cell specialization within human Peyer's patches: an ultrastructural study of intestinal lymphoid follicles. Gastroenterology 1974; 66: 189–203.
- 51 Wolf JL, Bye WA. The membranous epithelial (M) cell and the mucosal immune system. Annu Rev Med 1984; 35: 95–112.
- 52 Mantis NJ, Wagner J. Analysis of adhesion molecules involved in leukocyte homing into the basolateral pockets of mouse Peyer's patch M cells. J Drug Target 2004; 12: 79–87.
- 53 Pappo J, Owen RL. Absence of secretory component expression by epithelial cells overlying rabbit gut-associated lymphoid tissue. Gastroenterology 1988; 95: 1173–1177.
- 54 Owen RL, Bhalla DK. Cytochemical analysis of alkaline phosphatase and esterase activities and of lectin-binding and anionic sites in rat and mouse Peyer's patch M cells. Am J Anat 1983; 168: 199–212.
- 55 Clark MA, Jepson MA, Simmons NL, Booth TA, Hirst BH. Differential expression of lectin-binding sites defines mouse intestinal M-cells. J Histochem Cytochem 1993; 41: 1679–1687.
- 56 Lorenz RG, Chaplin DD, McDonald KG, McDonough JS, Newberry RD. Isolated lymphoid follicle formation is inducible and dependent upon lymphotoxin-sufficient B lymphocytes, lymphotoxin beta receptor, and TNF receptor I function. J Immunol 2003; 170: 5475–5482.
- 57 Buda A, Sands C, Jepson MA. Use of fluorescence imaging to investigate the structure and function of intestinal M cells. Adv Drug Deliv Rev 2005; 57: 123–134.
- 58 Jang MH, et al. Intestinal villous M cells: an antigen entry site in the mucosal epithelium. Proc Natl Acad Sci USA 2004; 101: 6110–6115.
- 59 Smith MW, James PS, Tivey DR. M cell numbers increase after transfer of SPF mice to a normal animal house environment. Am J Pathol 1987; 128: 385–389.
- 60 Savidge TC, Smith MW, James PS, Aldred P. Salmonella-induced M-cell formation in germ-free mouse Peyer's patch tissue. Am J Pathol 1991; 139: 177–187.
- 61 Borghesi C, Taussig MJ, Nicoletti C. Rapid appearance of M cells after microbial challenge is restricted at the periphery of the follicle-associated epithelium of Peyer's patch. Lab Invest 1999; 79: 1393–1401.
- 62 Kucharzik T, et al. Role of M cells in intestinal barrier function. Ann N Y Acad Sci 2000; 915: 171–183.
- 63 Gebert A, Steinmetz I, Fassbender S, Wendlandt KH. Antigen transport into Peyer's patches: increased uptake by constant numbers of M cells. Am J Pathol 2004; 164: 65–72.
- 64 Man AL, Prieto-Garcia ME, Nicoletti C. Improving M cell mediated transport across mucosal barriers: do certain bacteria hold the keys? Immunology 2004; 113: 15–22.
- 65 Neutra MR, Mantis NJ, Kraehenbuhl JP. Collaboration of epithelial cells with organized mucosal lymphoid tissues. Nat Immunol 2001; 2: 1004–1009.
- 66 Chambers SJ, Wickham MS, Regoli M, Bertelli E, Gunning PA, Nicoletti C. Rapid in vivo transport of proteins from digested allergen across pre-sensitized gut. Biochem Biophys Res Commun 2004; 325: 1258–1263.
- 67 Hershberg RM, Mayer LF. Antigen processing and presentation by intestinal epithelial cells – polarity and complexity. Immunol Today 2000; 21: 123–128.
- 68 Rey J, Garin N, Spertini F, Corthesy B. Targeting of secretory IgA to Peyer's patch dendritic and T cells after transport by intestinal M cells. J Immunol 2004; 172: 3026–3033.
- 69 Iwasaki A, Kelsall BL. Localization of distinct Peyer's patch dendritic cell subsets and their recruitment by chemokines macrophage inflammatory protein (MIP) -3alpha, MIP-3beta, and secondary lymphoid organ chemokine. J Exp Med 2000; 191: 1381–1394.
- 70 Cook DN, et al. CCR6 mediates dendritic cell localization, lymphocyte homeostasis, and immune responses in mucosal tissue. Immunity 2000; 12: 495–503.
- 71 De Togni P, et al. Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science 1994; 264: 703–707.
- 72 Mauri DN, et al. LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator. Immunity 1998; 8: 21–30.
- 73 Futterer A, Mink K, Luz A, Kosco-Vilbois MH, Pfeffer K. The lymphotoxin beta receptor controls organogenesis and affinity maturation in peripheral lymphoid tissues. Immunity 1998; 9: 59–70.
- 74 Scheu S, Alferink J, Potzel T, Barchet W, Kalinke U, Pfeffer K. Targeted disruption of LIGHT causes defects in costimulatory T cell activation and reveals cooperation with lymphotoxin beta in mesenteric lymph node genesis. J Exp Med 2002; 195: 1613–1624.
- 75 Alimzhanov MB, et al. Abnormal development of secondary lymphoid tissues in lymphotoxin beta-deficient mice. Proc Natl Acad Sci USA 1997; 94: 9302–9307.
- 76 Yin L, et al. Defective lymphotoxin-beta receptor-induced NF-kappaB transcriptional activity in NIK-deficient mice. Science 2001; 291: 2162–2165.
- 77 Miyawaki S, et al. A new mutation, aly, that induces a generalized lack of lymph nodes accompanied by immunodeficiency in mice. Eur J Immunol 1994; 24: 429–434.
- 78 Shinkura R, et al. Alymphoplasia is caused by a point mutation in the mouse gene encoding Nf-kappa b-inducing kinase. Nat Genet 1999; 22: 74–77.
- 79 Paxian S, et al. Abnormal organogenesis of Peyer's patches in mice deficient for NF-kappaB1, NF-kappaB2, and Bcl-3. Gastroenterology 2002; 122: 1853–1868.
- 80 Yilmaz ZB, Weih DS, Sivakumar V, Weih F. RelB is required for Peyer's patch development: differential regulation of p52-RelB by lymphotoxin and TNF. EMBO J 2003; 22: 121–130.
- 81 Matsushima A, et al. Essential role of nuclear factor (NF) -kappaB-inducing kinase and inhibitor of kappaB (IkappaB) kinase alpha in NF-kappaB activation through lymphotoxin beta receptor, but not through tumor necrosis factor receptor I. J Exp Med 2001; 193: 631–636.
- 82 Forster R, Mattis AE, Kremmer E, Wolf E, Brem G, Lipp M. A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen. Cell 1996; 87: 1037–1047.
- 83 Cupedo T, Mebius RE. Role of chemokines in the development of secondary and tertiary lymphoid tissues. Semin Immunol 2003; 15: 243–248.
- 84 Muller G, Hopken UE, Lipp M. The impact of CCR7 and CXCR5 on lymphoid organ development and systemic immunity. Immunol Rev 2003; 195: 117–135.
- 85 Muller G, Lipp M. Concerted action of the chemokine and lymphotoxin system in secondary lymphoid-organ development. Curr Opin Immunol 2003; 15: 217–224.
- 86 Mebius RE. Organogenesis of lymphoid tissues. Nat Rev Immunol 2003; 3: 292–303.
- 87 Spahn TW, Kucharzik T. Modulating the intestinal immune system: the role of lymphotoxin and GALT organs. Gut 2004; 53: 456–465.
- 88 Cao X, et al. Defective lymphoid development in mice lacking expression of the common cytokine receptor gamma chain. Immunity 1995; 2: 223–238.
- 89 Adachi S, et al. Essential role of IL-7 receptor alpha in the formation of Peyer's patch anlage. Int Immunol 1998; 10: 1–6.
- 90 Von Freeden-Jeffry U, Vieira P, Lucian LA, McNeil T, Burdach SE, Murray R. Lymphopenia in interleukin (IL) -7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. J Exp Med 1995; 181: 1519–1526.
- 91 McCracken VJ, Lorenz RG. The gastrointestinal ecosystem: a precarious alliance among epithelium, immunity and microbiota. Cell Microbiol 2001; 3: 1–11.
- 92 Spencer J, MacDonald TT, Finn T, Isaacson PG. The development of gut associated lymphoid tissue in the terminal ileum of fetal human intestine. Clin Exp Immunol 1986; 64: 536–543.
- 93 Dunn-Walters DK, Isaacson PG, Spencer J. Sequence analysis of human IgVH genes indicates that ileal lamina propria plasma cells are derived from Peyer's patches. Eur J Immunol 1997; 27: 463–467.
- 94 Fagarasan S, Honjo T. Regulation of IgA synthesis at mucosal surfaces. Curr Opin Immunol 2004; 16: 277–283.
- 95 Gardby E, Wrammert J, Schon K, Ekman L, Leanderson T, Lycke N. Strong differential regulation of serum and mucosal IgA responses as revealed in CD28-deficient mice using cholera toxin adjuvant. J Immunol 2003; 170: 55–63.
- 96 Yamamoto M, et al. Alternate mucosal immune system: organized Peyer's patches are not required for IgA responses in the gastrointestinal tract. J Immunol 2000; 164: 5184–5191.
- 97 Pabst O, et al. Chemokine receptor CCR9 contributes to the localization of plasma cells to the small intestine. J Exp Med 2004; 199: 411–416.
- 98 Berlin C, et al. Alpha 4 beta 7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1. Cell 1993; 74: 185–195.
- 99 Wilson AD, Bailey M, Williams NA, Stokes CR. The in vitro production of cytokines by mucosal lymphocytes immunized by oral administration of keyhole limpet hemocyanin using cholera toxin as an adjuvant. Eur J Immunol 1991; 21: 2333–2339.
- 100 Xu-Amano J, Aicher WK, Taguchi T, Kiyono H, McGhee JR. Selective induction of Th2 cells in murine Peyer's patches by oral immunization. Int Immunol 1992; 4: 433–445.
- 101 Daynes RA, Araneo BA, Dowell TA, Huang K, Dudley D. Regulation of murine lymphokine production in vivo. III. The lymphoid tissue microenvironment exerts regulatory influences over T helper cell function. J Exp Med 1990; 171: 979–996.
- 102 Kellermann SA, McEvoy LM. The Peyer's patch microenvironment suppresses T cell responses to chemokines and other stimuli. J Immunol 2001; 167: 682–690.
- 103 Iwasaki A, Kelsall BL. Freshly isolated Peyer's patch, but not spleen, dendritic cells produce interleukin 10 and induce the differentiation of T helper type 2 cells. J Exp Med 1999; 190: 229–239.
- 104 O'Garra A, Vieira P. Regulatory T cells and mechanisms of immune system control. Nat Med 2004; 10: 801–805.
- 105 Jump RL, Levine AD. Murine Peyer's patches favor development of an IL-10-secreting, regulatory T cell population. J Immunol 2002; 168: 6113–6119.
- 106 Tsuji NM, Mizumachi K, Kurisaki J. Interleukin-10-secreting Peyer's patch cells are responsible for active suppression in low-dose oral tolerance. Immunology 2001; 103: 458–464.
- 107 Tsuji NM, Mizumachi K, Kurisaki J. Antigen-specific, CD4+CD25+ regulatory T cell clones induced in Peyer's patches. Int Immunol 2003; 15: 525–534.
- 108 Strober W, Fuss I, Boirivant M, Kitani A. Insights into the mechanism of oral tolerance derived from the study of models of mucosal inflammation. Ann N Y Acad Sci 2004; 1029: 115–131.
- 109 Fujihashi K, et al. Peyer's patches are required for oral tolerance to proteins. Proc Natl Acad Sci USA 2001; 98: 3310–3315.
- 110
Spahn TW, et al.
Induction of oral tolerance to cellular immune responses in the absence of Peyer's patches.
Eur J Immunol
2001; 31: 1278–1287.
10.1002/1521-4141(200104)31:4<1278::AID-IMMU1278>3.0.CO;2-A CAS PubMed Web of Science® Google Scholar
- 111 Hauer AC, Bajaj-Elliott M, Williams CB, Walker-Smith JA, MacDonald TT. An analysis of interferon gamma, IL-4, IL-5 and IL-10 production by ELISPOT and quantitative reverse transcriptase-PCR in human Peyer's patches. Cytokine 1998; 10: 627–634.
- 112 Nagata S, et al. Human Peyer's patch T cells are sensitized to dietary antigen and display a Th cell type 1 cytokine profile. J Immunol 2000; 165: 5315–5321.
- 113 Monteleone G, et al. Activated STAT4 and a functional role for IL-12 in human Peyer's patches. J Immunol 2003; 170: 300–307.
- 114 Trinchieri G, Pflanz S, Kastelein RA. The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses. Immunity 2003; 19: 641–644.
- 115 MacDonald TT, Monteleone G. IL-12 and Th1 immune responses in human Peyer's patches. Trends Immunol 2001; 22: 244–247.
- 116 Moldoveanu Z, Oliver F, Mestecky J, Elson CO. Oral tolerance in humans: failure to suppress an existing immune response by oral antigen administration. Ann N Y Acad Sci 2004; 1029: 299–309.
- 117 Kato H, et al. Lack of oral tolerance in aging is due to sequential loss of Peyer's patch cell interactions. Int Immunol 2003; 15: 145–158.
- 118 Schmucker DL, Owen RL, Outenreath R, Thoreux K. Basis for the age-related decline in intestinal mucosal immunity. Clin Dev Immunol 2003; 10: 167–172.
- 119 Fujihashi K, McGhee JR. Mucosal immunity and tolerance in the elderly. Mech Ageing Dev 2004; 125: 889–898.
- 120 Dohi T, et al. Elimination of colonic patches with lymphotoxin beta receptor-Ig prevents Th2 cell-type colitis. J Immunol 2001; 167: 2781–2790.
- 121 Dohi T, Fujihashi K, Rennert PD, Iwatani K, Kiyono H, McGhee JR. Hapten-induced colitis is associated with colonic patch hypertrophy and T helper cell 2-type responses. J Exp Med 1999; 189: 1169–1180.
- 122 Spahn TW, et al. Induction of colitis in mice deficient of Peyer's patches and mesenteric lymph nodes is associated with increased disease severity and formation of colonic lymphoid patches. Am J Pathol 2002; 161: 2273–2282.
- 123 Nascimbeni R, Fabio FD, Betta ED, Mariani P, Fisogni S, Villanacci V. Morphology of colorectal lymphoid aggregates in cancer, diverticular and inflammatory bowel diseases. Mod Pathol 2005; 18: 681–685.
- 124 Walsh MC, Choi Y. Biology of the TRANCE axis. Cytokine Growth Factor Rev 2003; 4: 251–263.
- 125 Kim D, et al. Regulation of peripheral lymph node genesis by the tumor necrosis factor family member TRANCE. J Exp Med 2000; 192: 1467–1478.
- 126 Kong YY, et al. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 1999; 397: 315–323.
- 127 Dougall WC, et al. RANK is essential for osteoclast and lymph node development. Genes Dev 1999; 13: 2412–2424.
- 128 Naito A, et al. Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice. Genes Cells 1999; 4: 353–362.
- 129 Cupedo T, et al. Presumptive lymph node organizers are differentially represented in developing mesenteric and peripheral nodes. J Immunol 2004; 173: 2968–2975.
- 130 Cupedo T, Mebius RE. Cellular interactions in lymph node development. J Immunol 2005; 174: 21–25.
- 131 Williamson E, O'Malley JM, Viney JL. Visualizing the T-cell response elicited by oral administration of soluble protein antigen. Immunology 1999; 97: 565–572.
- 132 Kobayashi H, et al. In situ demonstration of dendritic cell migration from rat intestine to mesenteric lymph nodes: relationships to maturation and role of chemokines. J Leukoc Biol 2004; 75: 434–442.
- 133 Kunkel D, Kirchhoff D, Nishikawa S, Radbruch A, Scheffold A. Visualization of peptide presentation following oral application of antigen in normal and Peyer's patches-deficient mice. Eur J Immunol 2003; 33: 1292–1301.
- 134 Macpherson AJ, Uhr T. Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science 2004; 303: 1662–1665.
- 135
Spahn TW, et al.
Mesenteric lymph nodes are critical for the induction of high-dose oral tolerance in the absence of Peyer's patches.
Eur J Immunol
2002; 32: 1109–1113.
10.1002/1521-4141(200204)32:4<1109::AID-IMMU1109>3.0.CO;2-K CAS PubMed Web of Science® Google Scholar
- 136 Kang HS, et al. Signaling via LTbetaR on the lamina propria stromal cells of the gut is required for IgA production. Nat Immunol 2002; 3: 576–582.
- 137 Alpan O, Rudomen G, Matzinger P. The role of dendritic cells, B cells, and M cells in gut-oriented immune responses. J Immunol 2001; 166: 4843–4852.
- 138 Bjursten M, Hultgren Hornquist E. Dietary antigen-specific T-cell responses: switch from an interleukin-10-dominated response in normal mice to a T-helper 1 cytokine profile in Galphai2-deficient mice prior to colitis. Scand J Immunol 2005; 61: 29–35.
- 139 Rudolph U, et al. Gi2 alpha protein deficiency: a model of inflammatory bowel disease. J Clin Immunol 2005; 15: 101S–105S.
- 140 Hornquist CE, et al. G (alpha) i2-deficient mice with colitis exhibit a local increase in memory CD4+ T cells and proinflammatory Th1-type cytokines. J Immunol 1997; 158: 1068–1077.
- 141 Velazquez P, Wei B, Braun J. Surveillance B lymphocytes and mucosal immunoregulation. Springer Semin Immunopathol 2005; 26: 453–462.
- 142 Wei B, et al. Mesenteric B cells centrally inhibit CD4+ T cell colitis through interaction with regulatory T cell subsets. Proc Natl Acad Sci USA 2005; 102: 2010–2015.